A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients
Clinical trial NCT00190671 · COMPLETED
Trial details
- NCT number
- NCT00190671
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2008-03-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.